Plus: Sam Altman's home has been attacked twice in two days. This is today's edition of The Download, our weekday newsletter ...

That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...

Amid growing financial concerns and US vaccine hesitancy, the German company will close its mRNA site in Southeast Asia.

Shah Capital, which has agitated for change at the vaccine maker for years, is calling on fellow shareholders to end what it ...

Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...

Chief among its criticisms is Novavax's failure to build sales of its protein-based COVID-19 vaccine Nuvaxovid/Covovax, a ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

The messenger RNA (mRNA) market is undergoing significant expansion, driven by its versatile approach in treating and ...

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

Penn Medicine scientists blend AI and ingenuity to transform mRNA gene editing and personalized therapies redefining modern ...

Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...

BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other ...